Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Pancreatic Fistula 1Gastroparesis 1Anastomotic Leak 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Serum Albumin, Human × Gastrointestinal × Clear all
NCT04418739 2022-06-16

Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes

Universiti Kebangsaan Malaysia Medical Centre

Phase 2 Unknown
122 enrolled
Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms, Gastroparesis, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡